A PhaseⅠRandomised, Double-blind, Placebo-controlled, Study to Evaluate the Safety, Tolerability, and Pharmacokinetics Characteristics of the Oral Topical Use of GB001 Recombinant Peptide Spray in Chinese Healthy Adult Subjects
This trial is conducted in China. The aim of this clinical trial is to assess the safety , tolerability and pharmacokinetics profiles of GB001 by single ascending dose and multiple ascending doses in healthy subjects after topical buccal delivery.
100 Clinical Results associated with Zhejiang Echon Biopharm Limited
0 Patents (Medical) associated with Zhejiang Echon Biopharm Limited
100 Deals associated with Zhejiang Echon Biopharm Limited
100 Translational Medicine associated with Zhejiang Echon Biopharm Limited